FII Holdings

LAURUS LABS LTD.

NSE : LAURUSLABSBSE : 540222ISIN CODE : INE947Q01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE426.25-5.45 (-1.26 %)
PREV CLOSE ( ) 431.70
OPEN PRICE ( ) 429.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 83360
TODAY'S LOW / HIGH ( )423.20 431.45
52 WK LOW / HIGH ( )279.65 470.9
NSE426.50-4.9 (-1.14 %)
PREV CLOSE( ) 431.40
OPEN PRICE ( ) 429.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 426.50 (145)
VOLUME 1487447
TODAY'S LOW / HIGH( ) 423.50 431.30
52 WK LOW / HIGH ( )278.85 471
upfii downfii 
Current Quarter
Prev Quarter
Company Quarter Ended 202403 % of Share Quarter Ended 202312 % of Share Changeupfii

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.